BioFreedom Stent Superior in High Bleeding Risk Patients

ACC Conference Reporter

TCT 2015 | SAN FRANCISCO — A novel stent specifically designed to meet the needs of the substantial number of coronary artery disease patients who have a high-risk of bleeding halved the risk of clinically-driven target lesion revascularization compared to a bare metal stent. Read More >>>

Keywords: Transcatheter Cardiovascular Therapeutics

< Back to Listings